130 related articles for article (PubMed ID: 9125637)
1. Effective gastric acid suppression after oral administration of enteric-coated omeprazole granules.
Mohiuddin MA; Pursnani KG; Katzka DA; Gideon RM; Castell JA; Castell DO
Dig Dis Sci; 1997 Apr; 42(4):715-9. PubMed ID: 9125637
[TBL] [Abstract][Full Text] [Related]
2. The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non-encapsulated granules.
Sharma VK; Ugheoke EA; Vasudeva R; Howden CW
Aliment Pharmacol Ther; 1998 Nov; 12(11):1171-4. PubMed ID: 9845407
[TBL] [Abstract][Full Text] [Related]
3. Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy.
Sharma VK; Heinzelmann EJ; Steinberg EN; Vasudeva R; Howden CW
Am J Gastroenterol; 1997 May; 92(5):848-51. PubMed ID: 9149199
[TBL] [Abstract][Full Text] [Related]
4. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
[TBL] [Abstract][Full Text] [Related]
5. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
Miner PB; Fort JG; Zhang Y
Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 24-hour intragastric pH using four liquid formulations of lansoprazole and omeprazole.
Sharma VK
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S18-21. PubMed ID: 10597120
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube.
Larson C; Cavuto NJ; Flockhart DA; Weinberg RB
Dig Dis Sci; 1996 Mar; 41(3):475-9. PubMed ID: 8617118
[TBL] [Abstract][Full Text] [Related]
8. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
Thomson AB; Kirdeikis P; Lastiwka R; Röhss K; Sinclair P; Olofsson B
Can J Gastroenterol; 1997; 11(8):657-60. PubMed ID: 9459044
[TBL] [Abstract][Full Text] [Related]
10. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
Brummer RJ; Geerling BJ; Stockbrügger RW
Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148
[TBL] [Abstract][Full Text] [Related]
11. Simplified lansoprazole suspension--a liquid formulation of lansoprazole--effectively suppresses intragastric acidity when administered through a gastrostomy.
Sharma VK; Vasudeva R; Howden CW
Am J Gastroenterol; 1999 Jul; 94(7):1813-7. PubMed ID: 10406240
[TBL] [Abstract][Full Text] [Related]
12. In vitro study on capsule formulations of omeprazole containing enteric coated granules.
Pandey VP; Phanindrudu A; Manavalan R; Livingston J
Boll Chim Farm; 2002; 141(6):419-22. PubMed ID: 12577509
[TBL] [Abstract][Full Text] [Related]
13. Influence of acid secretory status on absorption of omeprazole from enteric coated granules.
Andersson T; Bergstrand R; Cederberg C
Br J Clin Pharmacol; 1991 Mar; 31(3):275-8. PubMed ID: 2054268
[TBL] [Abstract][Full Text] [Related]
14. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
[TBL] [Abstract][Full Text] [Related]
15. A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
Armas D; Holt RJ; Confer NF; Checani GC; Obaidi M; Xie Y; Brannagan M
Adv Ther; 2018 Feb; 35(2):199-209. PubMed ID: 29411268
[TBL] [Abstract][Full Text] [Related]
16. Effect of single-dose omeprazole and ranitidine on gastric juice acidity and volume in patients undergoing laparotomy.
Hendolin H; Suojaranta-Ylinen R; Alhava E
Acta Anaesthesiol Scand; 1993 Jul; 37(5):484-7. PubMed ID: 8356861
[TBL] [Abstract][Full Text] [Related]
17. Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
Balaban DH; Duckworth CW; Peura DA
Am J Gastroenterol; 1997 Jan; 92(1):79-83. PubMed ID: 8995942
[TBL] [Abstract][Full Text] [Related]
18. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
19. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients.
Cederberg C; Thomson AB; Mahachai V; Westin JA; Kirdeikis P; Fisher D; Zuk L; Marriage B
Gastroenterology; 1992 Sep; 103(3):913-8. PubMed ID: 1499942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
